Advancing AI in Life Sciences
Anthropic Buys Coefficient Bio for $400 Million
The acquisition aims to accelerate drug research by integrating biology-native AI into laboratory workflows.

A futuristic laboratory with digital displays of genetic data and artificial intelligence interfaces.
Photo: Avantgarde News
Anthropic acquired biotech startup Coefficient Bio for $400 million [1][2]. The startup develops AI models to automate laboratory workflows and drug research [1][3]. This move marks a significant expansion for Anthropic into the life sciences sector [2]. The Coefficient Bio team will join Anthropic’s healthcare and life sciences group [1]. They plan to build biology-native AI systems to speed up discovery processes [1][3]. The deal reflects growing interest in applying large language models to complex biological data [2].
Editorial notes
Transparency note
Drafted with LLM; human-edited
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
- 1.↗
benzinga.com
https://www.benzinga.com/m-a/26/04/51649388/anthropic-acquires-stealth-startup-coefficient-bio-400-million
- 2.↗
seekingalpha.com
https://seekingalpha.com/news/4572528-anthropic-scoops-up-biotech-startup-coefficient-bio-for-400m-report
- 3.↗
oncodaily.com
https://oncodaily.com/techology/anthropic479262
Related stories
View allTopics
About the author
Avantgarde News Desk covers advancing ai in life sciences and editorial analysis for Avantgarde News.


